XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Interim Condensed Consolidated Statement of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues [Abstract]    
Total revenue $ 38,286 $ 29,465
Total cost of sales 34,999 26,095
Gross profit 3,287 3,370
Expenses    
Sales and marketing 7,228 6,670
General and administrative 7,993 7,241
Operations support 2,498 2,297
Technology and development 2,140 1,935
Stock-based compensation 1,302 1,094
Reorganization 3,692  
Total operating expenses 24,853 19,237
Operating loss (21,566) (15,867)
Government subsidies 575 4,068
Foreign exchange loss (732) (180)
Interest income 11 19
Interest expense (1,330) (500)
Non Operating (income) loss (1,476) 3,407
Loss before tax (23,042) (12,460)
Income taxes    
Income tax expense   39
Net loss $ (23,042) (12,499)
Deferred tax expense   $ 39
Loss per share    
Basic and diluted loss per share $ (0.27) $ (0.15)
Weighted average number of shares outstanding (in thousands)    
Basic and Diluted 85,451 84,681
Product [Member]    
Revenues [Abstract]    
Total revenue $ 37,451 $ 28,542
Total cost of sales 34,607 23,551
Service [Member]    
Revenues [Abstract]    
Total revenue 835 923
Total cost of sales $ 392 788
Under-utilized Capacity [Member]    
Revenues [Abstract]    
Total cost of sales   $ 1,756